Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak
Giant Biogene (GB) raised around US$70m by pricing its HK IPO at the low-end. In this note we talk about the trading dynamics.
391 Views
Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets
Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.
403 Views
HK Short Interest Weekly: AIA, Li Auto, Wuxi Biologics, SHK PPT, CMB
We analyzed the latest HK SFC report for aggregate short position as of {} and highlight short interest changes in AIA, Li Auto, Wuxi Biologics,...
346 Views
Giant Biogene Pre-IPO - Thoughts on Valuation
Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.
391 Views
Giant Biogene Pre-IPO - Peer Comparison - Might Need to Spend a Lot More Online
Giant Biogene Holding aims to raise around US$500m in its Hong Kong IPO. In this note, we will undertake a peer comparison.
408 Views